2014-11-08T12:40:22-05:00 2013-12-31 JOHN M MONTICONE CPA 5 HIGH STREET SUITE 207 MEDFORD MA 02155 990 2013-01-01 043333682 BEDFORD RESEARCH FOUNDATION BEDF 53 CONCORD ROAD BEDFORD MA 01730 Dr Ann Kiessling PhD President 6176235670 2014-11-08 true JOHN M MONTICONE P01257043 7813950024 2014-11-08 X 2013 2015-11-30 17:44:51Z Dr Ann Kiessling PhD 528683 false X WWW.BEDFORDRESEARCH.ORG X 1996 MA Stem cell research, prostate disease research and HIV Research. 12 11 10 21 0 0 78350 56857 337646 413572 9234 8261 0 425230 478690 0 0 229747 249317 0 20339 291311 296481 521058 545798 -95828 -67108 366658 389961 13348 35175 353310 354786 Stem cell research, prostate disease research and HIV Research. false false 456613 393209 Special program of Assisted Reproduction takes advantage of Assited Reproduction Technology procedures to assist couples achieve a pregnancy who would otherwise risk transmitting the father's infection to the mother and the child through intercourse. During this process, researches gathered information to prevent the transmission of sexually transmitted deseases. HIV Research. 31639 20363 Post-Vasectomy test that provides CLIA certified laboratory results and used for prostate research. 488252 true true false false false false false false true true true false false false false false false false false false false false false false false false false false false false false false false false false false true false false false false false false false false false false true 1 0 true 10 true false false false false false false false false false false false false false false false X 12 11 false false false false false false false true false false false true true true false true true true false false MA X X Dr Ann Kiessling PhD 6176235670 53 CONCORD ROAD BEDFORD MA 01730 Dr Ann Kiessling PhD President 40.00 0.00 X X 55000 0 0 Alan S Geismer Esq Chairman 0.30 0.00 X X 0 0 0 Robert A Kaufmann MD Director 0.30 0.00 X 0 0 0 John D Lee Clerk 1.00 0.00 X X 0 0 0 Alan J Mayer Director 0.30 0.00 X 0 0 0 Susan L Moss JD PhD Director 0.30 0.00 X 0 0 0 Anil Purohit PhD Treasurer Director 1.00 0.00 X X 0 0 0 Sean J Kealy JD Director 0.30 0.00 X 0 0 0 Victoria Staebler Director 0.30 0.00 X 0 0 0 Margaret Wray Director 0.30 0.00 X 0 0 0 Lawrence R Jones MS Director 0.30 0.00 X 0 0 0 Jose Cibelli Director 0.30 0.00 X 0 0 0 55000 0 0 0 false false false 56857 56857 Assisted reproduction 621500 393209 393209 Semen analysis 621500 20363 20363 413572 8703 8703 49551 49993 -442 -442 -442 478690 413572 0 8261 55000 48125 4125 2750 169541 144754 13817 10970 7383 6349 443 591 17393 14958 1391 1044 2350 2350 4660 4660 5711 5711 6682 6682 89249 79432 7140 2677 2859 2401 229 229 17174 17174 3636 3636 3087 3087 Telephone 6396 4797 1279 320 Postages 5274 1758 1758 1758 Donor and Lab supplies 142738 142738 Subscriptions and membership 2029 2029 4636 1990 2646 545798 488252 37207 20339 54642 62061 22272 18655 4546 115628 110700 8564 4928 12319 28640 268861 271131 366658 389961 13348 35175 13348 35175 X 343310 354786 10000 353310 354786 366658 389961 -67108 68584 0 X true X false true false X 59745 182270 94859 78350 56857 472081 300189 333624 415523 337646 413572 1800554 359934 515894 510382 415996 470429 2272635 20000 144082 40000 25000 20000 249082 20000 144082 40000 25000 20000 249082 2023553 5941 3037 6109 9234 5000 29321 5941 3037 6109 9234 5000 29321 365875 518931 516491 425230 475429 2301956 0.87910 0.87310 0.01270 0.01250 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 10000 12000 22000 17000 15000 22000 10000 15000 5000 3000 17000 59500 44500 15000 false false 115628 110700 4928 4928 400 shares Coca-Cola Com 33048 F 400 shares Kimberly Clark 41784 F 500 shares Monsanto Co 58275 F 300 shares Exxon Mobil Corp 20240 F 500 shares Merk and Co 25025 F 300 Shares Procter & Gamble 24423 F 400 shares Prudential Financial 36888 F 800 Shares Vodafone Group 31448 F 271131 Dr Ann Kiessling PhD President 11003 The Organization perfomed laboratory services false Supplemental Information for Schedule L The Organization provided services to a related organization during the year 2013. The sole proprietor of this related organization is also the President of Bedford Research Foundation, Inc. The total fees received for this services was $11,003. These fees were reported by the Organization as Program Services. Committee meeting documentation Part VI line 8b No committee has the authority to act on behalf of the governing body. Form 990 governing body review Part VI line 11 Two weeks before filing the 990 form, a copy is given to each board of directors for review and discussion. Conflict of interest policy compliance Part VI line 12c The organization requires each new key employee, officer or director to review a copy of the Policy on Conflict of Interest and Disclosure of Certain Interests and to acknowledge in writing that he or she has done so. Additionally, each key employee, officer or director, annually complete a disclosure form identifying any relationships, positions or circumstances in which the employee is involved that he or she believes could contribute to a conflict of interest arising. CEO executive director top management comp Part VI line 15a The board of directors establishes the compensation for the Executive Director that are within the range or organizations similar in size and scope of Bedford Research Foundation. Governing documents etc available to public Part VI line 19 Copy of the financial statements and current year changes in the governing documents, conflict of interest policy are attached to the PC Form which is filed in the Secretary of State and available for public inspection. Also, copy of these documents are available at the organization's office at 53 Concord Road, Bedford, MA 01730, for public inspection upon request. Audited by an independent accountant Part XII line 2b The Organization's President and Treasurer have the responsibility to oversight the Review and the selection of the independent accountant. Explanation of other changes in net assets or fund balances Part XI line 9 Market Value appreciation of investments